Skip to main content

The Countdown Clock is Ticking

 And very son FOMO (the fear of missing out) will kick in.

I have a number of investments that are due to produce serious results before the end of the financial year (30 June). Let's have a look at them, in alphabetical order (I am not offering financial advice, just a commentary on where I am at with my investments):

1AI - actually, the result is due (probably) in July, but there is a chance that there will be an announcement sooner than that. These guys are doing amazing things with AI in the biomed sphere and will be a long-term winner )in my opinion). The next result should see a gain of at least 50% in their share price. In fact, as I write this their quarterly report has been released. After a quick read I am pleased to not have to change anything I just said. An announcement is due BY Q3. Happy days, only 2 months to go for that one.

BOT - Massive result due in late June. This should beest the share price by 150% from where it is now. These guys are also doing great and have a really solid follow-on. On product they do have up their sleeve is a synthetic cannabinoid, and that suggests that they might benefit from sharing a beer with 1AI to see if the two companies can work together. If that happens, watch out! Also, BOT is a takeover yatget by big Pharma. This particular space will become very exciting very quickly.

DTR 1 See my last 2 posts about this company. Anything COULD happen, but I feel that nothing will happen until at least October. When the others come through, this might be a good one to top up on.

DXB - like BOT, this is another WOW! stock. However, there are no clear dates on this one. While BOT is definately late-June, DXB is anytime. They are working on licensing deals for the USA and China, both of which are massive company-makers. This stock will probably increase 100% (a good time to sell) before retreating by about 30% (a good time to buy back in) before incresing again. And there are some interesting people who are comparing DXB's share price movements to that of NEU which went from where DXB is now (32 cents) to around $26 in less than 2 years. The imminent news about licensing deals is already steadily driving the share price up.

And that's where I am at and why.

Comments

Popular posts from this blog

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.

2025 - an early start

 Ok., so here we go on my Trump-era goal. Just bought MXR (yes, on the ASX). AAR wants to take them over at 7 cents as a scrip payment (paying in AAR shares instead of cash). The current share price is 6.3 cents. So that should be a quick 10% gain. However... this does look like a lowball offer and may yet be increased. MXR has great assets and AAR already owns almost 20% of MXR. So AAR is committed to a deal and that may just attract other attention. It looks like a no-brainer to start 2025. Yes, there is always some risk, but this one looks pretty good. I have done a bit more research and have some exciting thoughts, including one that looks a little like another WGO (which returned handsomely on a takeover). More news coming as I do more reseach.  Another one that looks good for a quick profit is GES, but as I write this, there are no shares at the right price (.05).

Out of 2

 I ahd some bills to pay and these 2 got the chop: PFE - such promise, such disappointmen IMC - I always had some ethical problems with this one.  But there it is. Bills paid, and a little left over to find something new with.